Victor Pikov Email & Phone Number

Greater Los Angeles Area

Stevenage, United Kingdom

The Bioelectronics Research Platforms under development include wirelessly-powered implantable devices for autonomic nerve stimulation, blocking, and recording and associated with them neural interfaces (primarily cuff electrodes). To develop these platforms, we work collaboratively with several commercial and academic partners. The pre-clinical research platforms for stimulation and blocking have already been deployed among our extensive Bioelectronics research network. Our effort is now focused on development and deployment of the clinical research platforms as well as the pre-clinical research platforms for closed-loop neuromodulation.

Stevenage, United Kingdom

Selection, testing, and deployment across GSK's research network of implantable platform technologies for autonomic nerve blocking, stimulation, and recording toward development of preclinical and clinical bioelectronic medicines

Pasadena, Ca

Advising the Bioelectronics R&D team and the Action Potential Venture Capital group at the GSK on neurophysiology, neurosurgery, and the design of impantable neuromodulation devices

Pasadena, Ca

Primary investigator on multiple grant projects (grant preparation, project execution, budget management, data analysis, and publication); supervisor of four technicians (animal care tech, surgical assistant, physiology tech, and histology/image processing tech); supervisor of post-doctoral and master students

Pasadena, Ca

Managed the selection process for top 20 candidates from a pool of 150+ applicants; chaired the Diversity Committee; matched admitted students with appropriate scientific mentors; participated in weekly meetings with students to discuss their progress; organized student’s final presentations; performed fund-raising for the program

Greater Los Angeles Area

At Dr. Baltimore’s molecular biology laboratory, I became acquainted with a set of viral vector tools for genetic manipulation of neurons and later applied them for making the lentiviral vector for Channelrhodopsin 2.